Carlyle Group Inc. (CGABL) — SC 13D/A Filings

SC 13D/A Filings (17)

• Carlyle Group Files 13D/A for QuidelOrtho — Nov 21, 2024 Risk: medium
  Carlyle Group Inc. filed an amendment to its Schedule 13D on November 21, 2024, related to its holdings in QuidelOrtho Corp. The filing indicates a change in be
• Carlyle Group Inc. SC 13D/A Filing - Amendment 16 — Nov 15, 2024 Risk: medium
  On November 15, 2024, CG Mgmt LLC filed an amendment (No. 16) to its Schedule 13D for The Carlyle Group Inc. The filing indicates a change in beneficial ownersh
• Carlyle Group Inc. Files SC 13D/A for Soleno Therapeutics — Oct 21, 2024 Risk: medium
  On October 21, 2024, Carlyle Group Inc. filed an SC 13D/A, indicating a change in its beneficial ownership of Soleno Therapeutics Inc. The filing details a grou
• Carlyle Group Amends Soleno Therapeutics Stake — Oct 15, 2024 Risk: medium
  Carlyle Group Inc. filed an amendment to its Schedule 13D on October 15, 2024, related to its holdings in Soleno Therapeutics Inc. The filing indicates a change
• Carlyle Group Inc. Files SC 13D/A Amendment — Oct 10, 2024 Risk: medium
  On October 10, 2024, Carlyle Group Inc. filed an SC 13D/A amendment, indicating a change in its beneficial ownership of Soleno Therapeutics Inc. The filing deta
• Carlyle Group Inc. Amends Soleno Therapeutics Stake — Sep 10, 2024 Risk: medium
  Carlyle Group Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of Soleno Therapeutics Inc. as of September 10, 2
• Carlyle Group Inc. Amends QuidelOrtho Stake Filing — Aug 5, 2024 Risk: medium
  Carlyle Group Inc. filed an amendment to its Schedule 13D on August 5, 2024, regarding its beneficial ownership of QuidelOrtho Corp. The filing indicates a chan
• Carlyle Group Files 13D/A for QuidelOrtho Corp — Jul 30, 2024 Risk: medium
  Carlyle Group Inc. filed an amendment to its Schedule 13D on July 30, 2024, related to its beneficial ownership of QuidelOrtho Corp. The filing indicates a chan
• Carlyle Group Amends QuidelOrtho Stake Filing — Jul 24, 2024 Risk: medium
  Carlyle Group Inc. filed an amendment to its Schedule 13D on July 24, 2024, related to its beneficial ownership of QuidelOrtho Corp. The filing indicates a chan
• Carlyle Group Inc. Amends QuidelOrtho Stake Filing — Jul 15, 2024 Risk: medium
  On July 15, 2024, Carlyle Group Inc. filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of QuidelOrtho Corp. The filing det
• Carlyle Group Inc. Amends QuidelOrtho Corp. Ownership Filing — Jun 25, 2024 Risk: medium
  Carlyle Group Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of QuidelOrtho Corp. as of June 25, 2024. The fil
• Carlyle Group Inc. Amends 13D Filing for QuidelOrtho Corp. — May 14, 2024 Risk: medium
  On May 14, 2024, Carlyle Group Inc. filed an amendment to its Schedule 13D, disclosing its beneficial ownership of QuidelOrtho Corp. The filing indicates that C
• Carlyle Group Inc. Amends Filing for eFFECTOR Therapeutics Stake — May 13, 2024 Risk: medium
  On May 13, 2024, Carlyle Group Inc. filed an SC 13D/A amendment regarding its holdings in eFFECTOR Therapeutics, Inc. The filing indicates a change in beneficia
• Carlyle Group Inc. Files SC 13D/A Amendment — Mar 5, 2024 Risk: low
  Carlyle Group Inc. filed an amendment (No. 15) to its Schedule 13D on March 5, 2024. The filing indicates changes in beneficial ownership for the company's comm
• Carlyle Group Amends Jasper Therapeutics Stake, Signals Ownership Update — Feb 12, 2024 Risk: low
  Carlyle Group Inc. filed an amended Schedule 13D/A on February 12, 2024, indicating a change in their beneficial ownership of Jasper Therapeutics, Inc. Voting C
• Carlyle Group Amends Adicet Bio Stake on Jan 25 Event — Feb 7, 2024
  Carlyle Group Inc. filed an amended Schedule 13D/A on February 7, 2024, indicating a change in their beneficial ownership of Adicet Bio, Inc. common stock. The
• Carlyle Group Amends CommScope Stake, Signals Ownership Change — Jan 3, 2024
  The Carlyle Group Inc. filed an amended Schedule 13D on January 3, 2024, indicating a change in their beneficial ownership of CommScope Holding Company, Inc. co

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX